ALL-206 Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country.

Mahmoud Hammad,Lobna Shalaby,Iman Sidhom,Nancy Sherief,Ibrahim Abdo,Sonia Soliman,Youssef Madeny,Reem Hassan,Shaimaa Elmeniawy,Nagwa Khamis,Iman Zaki,Tarek Mansour,Mohamed Gamal El-Ansary,Ahmed El-Halfawy,Sherif Abouelnaga,Alaa Elhaddad

Clinical lymphoma, myeloma & leukemia（2022）

Cited 0|Views5

No score

Abstract

Most pediatric cancer patients with COVID-19 should have good clinical outcomes, except for patients with critical infections. Cancer patients can tolerate chemotherapy, including induction phase, alongside COVID-19 treatment. In severe and critical COVID-19, RDV might have a potential benefit.

Translated text

Key words

ALL,COVID-19,SARS-CoV-2,immunocompromised patients,pediatric cancer,remdesivir

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined